Search Results 2651-2660 of 16382 for Chronic Lymphocytic Leukemia

1. Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma - Mayo Clinic

   Phase 4 trials look at long-term safety and effectiveness, after a new ... Chronic use of immune-suppressive drugs (ie, systemic corticosteroids used ...

2. Mayo Clinic

   Marla Broadfoot, Ph.D. November 8, 2024. Cardiovascular. Hourglass-shaped stent could ease severe chest pain ...

3. Curriculum - Blood and Marrow Transplant Fellowship (Florida) - Mayo Clinic College of Medicine & Science

   ... chronic graft-versus-host disease, and supportive care of transplanted patients. Transfusion medicine. Tissue typing. During this rotation, you gain ...

4. Cores - Mayo Clinic Research

   ... severe combined immunodeficiency (SCID) mice. In addition, these models spread throughout the peritoneal cavity, including omentum, just like the human ...

5. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

   Current diagnosis of chronic diarrheal illness with pre-CDI baseline diarrhea. This includes but is not limited to celiac disease, bile salt diarrhea ...

6. A Study to Evaluate the Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridium Difficile Infection - Mayo Clinic

   ... diagnosis and after treatment, to determine the effect of mucosa associated ... Prior diagnosis of C. difficile infection within 2 months of this ...

7. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

   Patients with histologically confirmed relapsed or refractory B-cell malignancies, including only patients with Grades 1-3a FL, MZL, MCL, and CLL/SLL.

8. A Study to Validate HPV DNA Genotyping and Prognostic Genomic Biomarkers for Diagnosis - Mayo Clinic

   A Study to Validate HPV DNA Genotyping and Prognostic Genomic Biomarkers for Diagnosis · Overview · Participation eligibility · Participating Mayo Clinic locations.

9. A study assessing esophageal function and remodeling with dupilumab compared with placebo for 24 weeks followed by 104 weeks open-label in adult participants with EoE - Mayo Clinic

   ... severe endocrinological, gastrointestinal, metabolic, pulmonary, psychiatric, or lymphatic diseases. The specific justification for participants excluded ...

10. A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects with Parkinson's Disease (PD) from other Movement Disorders - Mayo Clinic

    Phase 4 trials look at long-term ... Have a previous movement disorder diagnosis given by a movement disorders specialist prior to the time of enrollment; ...